Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)

NCT06357975

Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +19 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma

NCT04726501

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: West China Second University Hospital, Sichuan University, Chengdu, China Chengdu, China

Nanjing Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China Nanjing, China

Shanghai Children's Medical Center Shanghai, China

View Trial Details

Active, Not Recruiting

Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma

NCT07480837

Conditions: B-Cell Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Active, Not Recruiting

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

NCT02952508

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Central Nervous System Lymphoma, +36 more
Locations: Cellectar Biosciences site Los Angeles, California, United States

Cellectar Biosciences site Redlands, California, United States

Cellectar Biosciences site Washington D.C., District of Columbia, United States

Cellectar Biosciences site Jacksonville, Florida, United States

View all 52 locations

View Trial Details

Active, Not Recruiting

Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

NCT04635384

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations: University of California Irvine Brisbane, California, United States

City of Hope Duarte, California, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Georgia Cancer Center at Augusta University Augusta, Georgia, United States

View Trial Details

Active, Not Recruiting

Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma

NCT07480850

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing, Beijing, China

View Trial Details

Active, Not Recruiting

LBL-2016 for Children or Adolescents in China

NCT02845882

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: West China Second University Hospital Chengdu, China

Shanghai Children's Medical Center Shanghai, China

View Trial Details

Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations: Lucile Packard Children's Hospital Palo Alto, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

Duke University Chapel Hill, North Carolina, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Active, Not Recruiting

Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

NCT03663933

Conditions: Autoimmune Diseases, Autoimmune Lymphoproliferative, Common Variable Immunodeficiency, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

National Marrow Donor Program Minneapolis, Minnesota, United States

View Trial Details

Active, Not Recruiting

Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL

NCT05478512

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Ematologia AOU Careggi Florence, Italy

Ematologia IRST D.Amadori Meldola, Italy

Ematologia AO di Perugia Perugia, Italy

Ematologia Ospedale S.M. delle Croci Ravenna, Italy

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions